Effects of human immunodeficiency virus and colony-stimulating factors on the production of interleukin 6 and tumor necrosis factor a by monocyte/macrophages

AIDS Research and Human Retroviruses

Volumn 13, Issue 10, 1997, Pages 829-839

  Foli, Andrea ^a   Wayne Saville, M ^a   May, Lester T ^b   Webb, Deborah S A ^c   Yarchoan, Robert ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; NEUTRALIZING ANTIBODY; ONCOSTATIN M; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

EID: 0030969553     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.829     Document Type: Article

References (68)

1. Wright SC, Jewett A, Mitsuyasu R, and Bonavida B: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988;141: 90-104.
2. Roux-Lombard P, Modoux C, Cruchaud A, and Dayer J-M: Purified blood monocytes from HIV 1-infected patients produce high levels of TNF-alpha and IL-1. Clin Immunol Immunopathol 1989;50:374-384.
3. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, and Martinez-Maza O: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-484.
4. Rieckmann P, Poli G, Kehrl JH, and Fauci AS: Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J Exp Med 1991;173:1-5.
5. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, and Meroni PL: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8: 757-762.
6. Gurram M, Chirmule N, Wang XP, Ponugoti N, and Pahwa S: Increased spontaneous secretion of interleukin 6 and tumor necrosis factor alpha by peripheral blood lymphocytes of human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13: 496-501.
7. Lathey JL, Kanangat S, Rouse BT, Agosti JM, and Spector SA: Dysregulation of cytokine expression in monocytes from HIV-positive individuals. J Leuk Biol 1994;56:347-352.
8. Lathey JL, Kanangat S, and Rouse BT: Differential expression of tumor necrosis factor alpha and interleukin-1 beta compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J Acquir Immune Defic Syndr 1994;7:109-115.
9. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, and Fauci AS: Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989;86:2365-2368.
10. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, and Fauci AS: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172:151-158.
11. Kinter AL, Poli G, Fox L, Hardy E, and Fauci AS: HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by exogenous cytokines. J Immunol 1995;154:2448-2459.
12. Pluda JM, Venzon DJ, Tosato G, Lietzau J, Wyvill K, Nelson DL, Jaffe ES, Karp JE, Broder S, and Yarchoan R: Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993;11:1099-1107.
13. 2) production by HIV. J Immunol 1989;142:531-536.
14. Merrill JE, Koyanagi Y, and Chen IS: IL-1 and TNF-alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989;63:4404-4408.
15. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, and Tosato G: Induction of IL-6 during human immunodeficiency virus infection. Blood 1990;76:2303-2310.
16. Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, and Farrar WL: The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991;147:2892-2901.
17. Esser R, von Briesen H, Brugger W, Ceska M, Glienke W, Muller S, Rehm A, Rubsamen-Waigmann H, and Andreesen R: Secretory repertoire of HIV-infected human monocytes/macrophages. Pathobiology 1991;59:219-222.
18. Mabondzo A, Le NR, Raoul H, Clayette P, Lafuma C, Barre SF, Cayre Y, and Dormont D: In vitro infection of macrophages by HIV: Correlation with cellular activation, synthesis of tumour necrosis factor alpha and proteolytic activity. Res Virol 1991;142: 205-212.
19. Than S, Oyaizu N, Pahwa RN, Kalyanaraman VS, and Pahwa S: Effect of human immunodeficiency virus type-1 envelope glycoprotein gp160 on cytokine production from cord-blood T cells. Blood 1994;84:184-188.
20. Sandborg C, Imfeld K, Zaldivar F, and Berman M: HIV type 1 induction of Interleukin 1 and 6 production by human thymic cells. AIDS Res Hum Retroviruses 1994;10:1221-1229.
21. Ameglio F, Capobianchi MR, Castilletti C, Cordiali FP, Fais S, Trento E, and Dianzani F: Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol 1994;95:455-458.
22. Berman M, Zaldivar F, Imfeld K, Kenney J, and Sandborg C: HIV-1 infection of macrophages promotes long-term survival and sustained release of interleukins 1alpha and 6. AIDS Res Hum Retroviruses 1994;10:529-539.
23. Molina J-M, Schindler R, Ferriani R, Sakaguchi M, Vannier E, Dinarello CA, and Groopman JE: Production of cytokines by peripheral blood monocytes/macrophages infected by human immunodeficiency virus type 1 (HIV-1). J Infect Dis 1990;161: 888-893.
24. Molina J-M, Scadden DT, Amirault C, Woon A, Vannier E, Dinarello CA, and Groopman JE: Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol 1990;64:2901-2906.
25. D'Addario M, Roulston A, Wainberg MA, and Hiscott J: Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells. J Virol 1990;64:6080-6089.
26. Meltzer MS, Baca L, Turpin JA, Kalter DC, Dieffenbach C, Friedman RM, and Gendelman HE: Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus. Pathobiology 1991;59:209-213.
27. Gan H, Ruef C, Hall BF, Tobin E, Remold HG, and Mellors JW: Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses 1991;7:671-679.
28. Sperber K, Hamrang G, Louie MJ, Kalb T, Banerjee R, Choi HS, Paronetto F, and Mayer L: Progressive impairment of monocytic function in HIV-1-infected human macrophage hybridomas. AIDS Res Hum Retroviruses 1993;9:657-667.
29. Oyaizu N, Chirmule YO, Kalyanaraman VS, and Pahwa S: Human Immunodeficiency virus type 1 envelope glycoproteins gp 120 and gp 160 induce interleukin-6 production in CD4+ T-cell clones. J Virol 1991;65:6277-6282.
30. Rieckmann P, Poli G, Fox CH, Kehrl JH, and Fauci AS: Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 1991;147:2922-2927.
31. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, and Ensoli B: Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992;66:7159-7167.
32. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, and Venuta S: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 1994;179:961-971.
33. Iwamoto GK, Konicek SA, and Twigg HR: Modulation of accessory cell function and interleukin-6 production by the HIV-1 tat gene. Am J Respir Cell Mol Biol 1994;10:580-585.
34. Rautonen J, Rautonen N, Martin N, and Wara D: HIV type 1 Tat protein induces immunoglobulin and interleukin 6 sythesis by uninfected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1994;10:781-785.
35. Gerrard TL, Jurgensen CH, and Fauci AS: Differential effect of monoclonal anti-DR antibody on monocytes in antigen- or mitogen-stimulated response: Mechanism of inhibition and relationship to interleukin-1 secretion. Cell Immunol 1983;82:394-401.
36. Perno C-F and Yarchoan R: Culture of HIV in monocytes and macrophages. In: Current Protocols in Immunology (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, eds.), Vol. 2. Greene Publishers-Wiley Interscience, New York, 1993, pp. 12.4.1-12.4.11.
37. Johnson VA and Byington RE: Quantitative assays for virus infectivity. In: Techniques in HIV Research (Aldovini A and Walker BD, eds.). Stockton Press, New York, 1990, pp. 71-76.
38. Broxmeyer HE, Moore MAS, and Ralph P: Cell-free granulocyte inhibiting activity derived from human polymorphonuclear neutrophils. Exp Hematol 1977;5:87-102.
39. Aarden LA, DeGroot ER, Schaap DL, and Landsorp PJ: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-1416.
40. May LT, Viguet H, Kenney JS, Ida N, Allison AC, and Sehgal PB: High levels of complexed interleukin-6 in human blood. J Biol Chem 1992;267:19698-19704.
41. May LT, Santhanam U, and Sehgal PB: On the multimeric nature of natural human interleukin-6. J Biol Chem 1991;266:9950-9955.
42. Folks TM, Justement J, Kinter A, Dinarello CA, and Fauci AS: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800-802.
43. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, and Chen ISY: Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988;241:1673-1675.
44. Perno C-F, Yarchoan R, Cooney DA, Hartman NR, Webb DSA, Hao Z, Mitsuya H, Johns DG, and Broder S: Replication of human immunodeficiency virus in monocytes: Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′,3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989;169:933-951.
45. Clouse KA, Robbins PB, Fernie B, Ostrove JM, and Fauci AS: Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. J Immunol 1989;143:470-475.
46. Navarro S, Debili N, Bernaudin J, Vainchenker W, and Doly J: Regulation of the expression of IL-6 in human monocytes. J Immunol 1989;142:4339-4345.
47. Bauer J, Ganter U, Geiger T, Jacobshagen U, Hirano T, Matsuda T, Hishimoto T, Andus T, Acs G, Gerok W, and Ciliberto G: Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 1988;72:1134-1140.
48. Tamburrini E, De Luca A, Ventura G, Maiuro G, Siracusano A, Ortona E, and Antinori A: P. carinii induces TNF-alpha production by macrophages. In: VII International Conference on AIDS, Florence, Italy, 1991, Vol. 1 Instituto Superiore di Sanità, Rome, Italy.
49. Northoff H, Andus T, Tran-Thi TA, Bauer J, Decker K, Kubanek B, and Heinrich PC: The inflammation mediators interleukin 1 and hepatocyte-stimulating factor are differently regulated in human monocytes. Eur J Immunol 1987;17:707-711.
50. Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Sehgal PB, and May LT: IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J Immunol 1989;143:2153-2159.
51. Locksley RM, Crowe S, Sadick MD, Heinzel FP, Gardner KJ, McGrath MS, and Mills J: Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. J Clin Invest 1988;82:2097-2105.
52. Rimaniol AC, Boussin F, Herbelin A, De Groote D, Dormont D, Bach JF, Descamps L, and Zavala F: Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes. Eur J Immunol 1994;24:2055-2060.
53. Gallo P, Pagni S, Giometto B, Piccinno MG, Bozza F, Argentiero V, and Tavolato B: Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. J Neuroimmunol 1990;29:105-112.
54. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono A, Raiteri R, and Gioannini P: Cytokine network and acute primary HIV infection. AIDS 1993;7:1167-1172.
55. 2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
56. Pantaleo G, Graziosi C, and Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. New Engl J Med 1993;328:327-335.
57. Denis M and Ghadirian E: Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1 alpha (MIP-1 alpha): Contribution to the CD8+ alveolitis. Clin Exp Immunol 1994;96:187-192.
58. Kandil O, Fishman JA, Koziel H, Pinkston P, Rose RM, and Remold HG: Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994;62:644-650.
59. Moore PS, Boshoff C, Weiss RA, and Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-1744.
60. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein L, and Gendelman H: Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-1718.
61. Agostini C, Trentin L, Zambello R, Bulian P, Caenazzo C, Cipriani A, Cadrobbi P, Garbisa S, and Semenzato G: Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1 infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992;149:3379-3385.
62. Beutler B and Cerami A: Cachectin: More than a tumor necrosis factor. N Engl J Med 1987;316:379-385.
63. Kishimoto T: The biology of interleukin-6. Blood 1989;74:1-10.
64. Thomassen MJ, Ahmad M, Barna BP, Antal J, Wiedemann HP, Meeker DP, Klein J, Bauer L, Gibson V, Andresen S, and Bukowski RM: Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy. Cancer Res 1991;51:857-862.
65. Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, and Broder S: Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 1990;76:463-472.
66. Kaplan LD, Kahn JO, Crowe S, Northfelkt D, Neville P, Grossberg H, Abrams DI, Tracy J, Mills J, and Volberding PA: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol 1991;9:929-940.
67. Fazely F, Dezube BJ, Allen RJ, Pardee AB, and Ruprecht RM: Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 1991;77:1653-1656.
68. Honda M, Yamamoto S, Cheng M, Yasugawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, and Kishimoto T: Human soluble IL-6 recetor: Its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-2180.